➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: April 16, 2021

DrugPatentWatch Database Preview

BOTOX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BOTOX

Patents:	49
Applicants:	1
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for BOTOX
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for BOTOX

Drug Prices for BOTOX

See drug prices for BOTOX

Recent Litigation for BOTOX

Identify key patents and potential future biosimilar entrants

District Court Litigation

Case Name	Date
In re: Aoki	2013-07-30

See all BOTOX litigation

PTAB Litigation

Petitioner	Date
	2017-02-21

See all BOTOX litigation

Pharmacology for BOTOX

Mechanism of Action	Acetylcholine Release Inhibitors

Company Disclosures: US Patents for BOTOX

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	The Regents of the University of Colorado (Boulder, CO)	2017-07-15	RX		company
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	Allergan, Inc. (Irvine, CA)	2013-12-28	RX		company
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	Allergan, Inc. (Irvine, CA)	2013-12-28	RX		company
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	Allergan, Inc. (Irvine, CA)	2013-12-28	RX		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for BOTOX

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX		search
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	NANOMED SKINCARE, INC. (Cupertino, CA)	2039-02-26	RX		search
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial	Allergan, Inc. (Irvine, CA)	2039-02-26	RX		search
Allergan	BOTOX	onabotulinumtoxina	VIAL; SINGLE-USE	103000	001	1991-12-09	Start Trial		2034-03-16	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BOTOX

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2017079459	Start Trial
Hungary	E030094	Start Trial
European Patent Office	1103267	Start Trial
Chile	2019000760	Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for BOTOX

Subscribe to access the full database, or Start Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
SPC/GB13/078	United Kingdom	Start Trial	PRODUCT NAME: BOTULINUM TOXIN TYPE A; REGISTERED: FI 263103-5/2012 20130116; UK PL 00426/0118 - 0061 20130904; UK PL 00426/0074 - 0139 20130904; UK PL 00426/0119 - 0047 20130904
122008000043	Germany	Start Trial	PRODUCT NAME: CLOSTRIDIUM BOTULINUM NEUROTOXIN TYP A (150KD), FREI VON KOMPLEXPROTEINEN; REGISTRATION NO/DATE: 57093.00.00 20050531
132013902177250	Italy	Start Trial	PRODUCT NAME: TOSSINA BOTULINICA DI TIPO A(BOTOX); AUTHORISATION NUMBER(S) AND DATE(S): NL25449, 20110826;034883013/M, 20130123
2013C/047	Belgium	Start Trial	PRODUCT NAME: TOXINE BOTULIQUE TYPE A; AUTHORISATION NUMBER AND DATE: 263103-5/2012 20130128
>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Mallinckrodt

Boehringer Ingelheim

Johnson and Johnson

Medtronic

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.